Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing 100730, China.
Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing 100730, China.
Eur J Pharmacol. 2019 May 15;851:1-12. doi: 10.1016/j.ejphar.2019.02.015. Epub 2019 Feb 12.
Cisplatin is a widely used chemotherapeutic drug that often causes acute kidney injury (AKI) in cancer patients. The contribution of miRNAs to the cisplatin-induced renal tubular epithelial cell injury remains largely unknown. Here we performed an integrative network analysis of miRNA and mRNA expression profiles to shed light into the underlying mechanism of cisplatin-induced renal tubular epithelial cell injury. Microarray analysis identified 47 differentially expressed miRNAs, among them 26 were upregulated and 21 were downregulated. Moreover, integrating dysregulated miRNAs target prediction and altered mRNA expression enabled us to identify 1181 putative target genes for further bioinformatics analysis. Gene ontology (GO) analysis revealed that the putative target genes were involved in apoptosis process and regulation of transcription. Pathway analysis indicated that the top upregulated pathways included MAPK and p53 signaling pathway, while the top downregulated pathways were PI3K-Akt and Wnt signaling pathway. Further network analysis showed that MAPK signaling pathway and apoptosis with the highest degree were identified as core pathways, hsa-miR-9-3p and hsa-miR-371b-5p as the most critical miRNAs, and CASK, ASH1L, CDK6 etc. as hub target genes. In addition, the expression level change of selected five microRNAs (hsa-miR-4299, hsa-miR-297, hsa-miR-3135b, hsa-miR-9-3p, and hsa-miR-371b-5p) and two mRNAs( CASK and CDK6) were validated in cisplatin-induced HK-2 cells. Furthermore, a similar trend of expression level change was observed in NRK-52E cells by cisplatin treatment. Overall, our results provide the molecular basis and potential targets for the treatment of cisplatin-induced renal tubular cell injury.
顺铂是一种广泛应用的化疗药物,常导致癌症患者发生急性肾损伤(AKI)。miRNA 对顺铂诱导的肾小管上皮细胞损伤的贡献在很大程度上仍不清楚。在此,我们进行了 miRNA 和 mRNA 表达谱的综合网络分析,以期深入了解顺铂诱导的肾小管上皮细胞损伤的潜在机制。微阵列分析确定了 47 个差异表达的 miRNA,其中 26 个上调,21 个下调。此外,整合失调的 miRNA 靶标预测和改变的 mRNA 表达使我们能够鉴定出 1181 个潜在的靶基因进行进一步的生物信息学分析。基因本体(GO)分析表明,潜在的靶基因参与凋亡过程和转录调控。通路分析表明,上调的通路包括 MAPK 和 p53 信号通路,而下调的通路包括 PI3K-Akt 和 Wnt 信号通路。进一步的网络分析表明,MAPK 信号通路和凋亡被鉴定为核心通路,hsa-miR-9-3p 和 hsa-miR-371b-5p 为最关键的 miRNA,CASK、ASH1L、CDK6 等为枢纽靶基因。此外,还验证了顺铂诱导的 HK-2 细胞中选定的五个 miRNA(hsa-miR-4299、hsa-miR-297、hsa-miR-3135b、hsa-miR-9-3p 和 hsa-miR-371b-5p)和两个 mRNA(CASK 和 CDK6)的表达水平变化。此外,顺铂处理后在 NRK-52E 细胞中观察到类似的表达水平变化趋势。总之,我们的研究结果为顺铂诱导的肾小管细胞损伤的治疗提供了分子基础和潜在靶点。